These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: PAF and PDGF increase cytosolic [Ca2+] and phospholipase activity in mesangial cells.
    Author: Bonventre JV, Weber PC, Gronich JH.
    Journal: Am J Physiol; 1988 Jan; 254(1 Pt 2):F87-94. PubMed ID: 3337246.
    Abstract:
    Platelet-activating factor (PAF) and platelet-derived growth factor (PDGF) likely play important roles in glomerular processes. To identify mechanisms of PAF- and PDGF-induced mesangial cell activation, we characterized effects of both agents on cytosolic free [Ca2+] ([Ca2+]f) and phospholipase activation. When cultured rat renal mesangial cells were stimulated by PAF, [Ca2+]f increased (within 10 s) from 110 +/- 6 to 209 +/- 14 nM, due to release of Ca2+ from intracellular storage sites, as well as entry of Ca2+ from external milieu. PAF also rapidly increased free arachidonate, diacylglycerol, and inositol trisphosphate (IP3) levels. PDGF increased [Ca2+]f from 78 +/- 12 to 192 +/- 22 nM, but the time response was different from that seen with PAF. Peak [Ca2+]f increase occurred at approximately 1 min subsequent to stimulation. Like PAF, increased [Ca2+]f was due to release of Ca2+ from intracellular stores and entry from extracellular media. PDGF increased levels of free arachidonate prior to an increase in diacylglycerol levels. PDGF increased inositol bisphosphate and IP3 levels at 2 min but not at 15 s. Thus, PDGF may mediate a phospholipase C-independent activation of phospholipase A2. In permeabilized mesangial cells, IP3 released Ca2+ from nonmitochondrial storage sites. Thus, PAF- and PDGF-induced increases in [Ca2+]f were likely secondary to activation of phospholipase C, resulting in increased levels of IP3. Understanding differences in mechanisms of mesangial cell activation by PAF and PDGF will likely lead to a better understanding of signal transduction pathways and provide insight into the role of these activators in glomerular disease.
    [Abstract] [Full Text] [Related] [New Search]